With 7.1% CAGR, Plasma Fractionation Market Size valued at USD

Pune, India, August 25, 2022 (GLOBE NEWSWIRE) —

global plasma fractionation market the size was 28.69 billion dollars in 2021. The market is projected to grow from 30.64 billion dollars in 2022 until 49.61 billion dollars until 2029 in one CAGR of 7.1% during the period 2022-2029. Fortune Business Insights™ publishes this information in a report entitled, “Plasma Fractionation Market, 2022-2029″. According to the report, the market is anticipated to grow during the forecast period due to the rise in immune deficiency disorders among the population.

Get the sample PDF brochure:

https://www.fortunebusinessinsights.com/enquiry/sample/plasma-fractionation-market-101614

Plasma fractionation market Scope and segmentation of the report:

Impact of COVID-19:

Limited plasma collection activities hampered the market growth

The COVID-19 pandemic affected many different industries due to restrictions and strict restrictions on operations. Also, plasma collection practices were disrupted, impacting the growth of the plasma fractionation market during the pandemic period. Also, due to the increase in the number of cases of COVID-19, hospitals were completely overwhelmed by emergency cases, and plasma therapies for non-critical conditions were not a priority during the initial phase of the lockdown.

Segments:

The protease inhibitor segment will grow significantly

By product, the plasma fractionation market is categorized into immunoglobulin, albumin, coagulation factors, protease inhibitors, and others. The protease inhibitors segment is projected to dominate the global market due to increasing product demand. Also, the immunoglobulin segment is further sub-segmented into intravenous immunoglobulin and subcutaneous immunoglobulin. Coagulation factors are sub-segmented into factor IX, factor VIII, prothrombin complex concentrates, fibrinogen concentrates and others.

To learn more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

The immunology and neurology segment leads the market due to high adoption of plasma proteins

On the basis of application, the market is segmented into immunology and neurology, hematology, critical care, pulmonology, and others. The immunology and neurology segment holds a dominant share of the market due to increasing adoption of plasma proteins.

Hospitals and clinics will dominate the global market due to increasing demand in medical procedures

On the basis of end user, the market has tripled into hospitals and clinics, clinical research laboratories and others. The hospital and clinic segment is projected to grow significantly due to increasing demand for plasma products in many medical procedures.

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Quick Buy – Plasma Fractionation Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/101614

Report coverage:

The report provides thoroughly analyzed data on the latest trends and developments in the market. Also, the drivers and restraints affecting the growth of the market during the forecast period are also mentioned in this report. The impact of the COVID-19 pandemic on the expansion of the global market is highlighted in the report, along with the latest developments presented by key market players. Furthermore, regional insights into the segmented areas of the market are provided along with a list of key market players.

Drivers and restrictions:

Increasing demand for plasma-derived medicinal products to enhance growth

The market is expected to witness significant growth during the forecast period. The launch of new technologies by the major market players is expected to strengthen the market growth. Also, the increasing incidence of immunodeficiency disorders is expected to drive the development and expansion of the market during the forecast period. Moreover, the growing demand for plasma-derived medicinal products increased the market reach in both developed and developing countries.

However, the emergence of recombinant therapies as an alternative to plasma-derived drugs may hamper market growth.

Regional insights:

North America holds the dominant market share due to increasing technical advancements

North America dominates the global plasma fractionation market share due to increasing technological advancements in the market. The regional market recorded USD 16.10 billion in 2021. Furthermore, the presence of leading companies in the market is anticipated to drive the growth of the regional market.

Talk to our analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/plasma-fractionation-market-101614

Competitive landscape:

Strategic acquisition allows companies to drive growth

The leading players of the Plasma Fractionation market implement different strategies to improve their business performance. Companies create strategic alliances, partnerships, mergers and acquisitions to expand the scope of their business and strengthen their position in the market.

Key industry developments:

• January 2022: Bio Products Laboratory Ltd. announced that the National Medical Products Administration (NMPA) for China granted the company a license to market ALBUMINEX 25% in China.

List of top players profiled in Report:

• CSL (USA)
• Grifols, SA (Spain)
• Takeda Pharmaceutical Company Limited (Japan)
• Kedrion SpA (Italy)
• Octapharma (Switzerland)
• Bio Products Laboratory Ltd. (UK)
• Biotest AG (Germany)
• LFB (France)

Table of Contents:

• presentation
  • Research Area
  • Market segmentation
  • Research methodology
  • Definitions and assumptions
• Executive Summary
• Market Dynamics
  • Market leaders
  • Market restrictions
  • Market Opportunities
  • Market Trends
• Key insights
  • Number of plasma collection centers for major countries
  • Plasma Fractionation Capacity and Capacity Utilization Rate for Key Players
  • Plasma fractionation cost breakdown by country
  • Regional Distribution of Plasma Fractionation Propagation
  • Global Plasma Fractionation Market Distribution (Volume), By Region
  • Recent industry developments – Partnerships, mergers and acquisitions
  • Regulatory scenario by major countries
  • Prevalence of chronic diseases (main indications) by main countries
  • Summary: Plasma collection technologies

• • Pipeline analysis, by major companies
  • Price analysis of plasma products by major countries
  • Impact of the COVID-19 Pandemic on the Plasma Fractionation Market

• Global Plasma Fractionation Market Analysis, Insights and Forecast, 2018-2029
  • Key Findings / Summary
  • Market Analysis, Insights and Forecasts – By Product

• • • • Intravenous immunoglobulin (IVIG)
      • Subcutaneous immunoglobulin (SCIG)

• • • • Factor IX
      • Factor VIII
      • Prothrombin complex concentrations
      • Fibrinogen concentrates
      • Others

• North America Plasma Fractionation Market Analysis, Insights and Forecasts, 2018-2029
  • Key Findings / Summary
  • Market Analysis, Insights and Forecasts – By Product
• • Market Analysis, Insights and Forecasts – By Application
    • Immunology & Neurology
    • Hematology
    • Critical Care
    • Pulmonology
    • Others
  • Market Analysis, Insights and Forecasts – By the End User
    • Hospitals and Clinics
    • Clinical Research Laboratories
    • Other (Academic Institutes, etc.)
  • Market Analysis, Insights and Forecasts – By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • • Protease inhibitors
    • Others

• • • • Intravenous immunoglobulin (IVIG)
      • Subcutaneous immunoglobulin (SCIG)

• • • • Factor IX
      • Factor VIII
      • Prothrombin complex concentrations
      • Fibrinogen concentrates
      • Others

• • Market Analysis, Insights and Forecasts – By Application
    • Immunology & Neurology
    • Hematology
    • Critical Care
    • Pulmonology
    • Others
  • Market Analysis, Insights and Forecasts – By the End User
    • Hospitals and Clinics
    • Clinical Research Laboratories
    • Other (Academic Institutes, etc.)
  • Market Analysis, Insights and Forecasts – By Country
  • • Protease inhibitors
    • Others

Toc Continue..

Request customization of this report:

https://www.fortunebusinessinsights.com/enquiry/customization/plasma-fractionation-market-101614

Frequently Asked Questions:

1. How much is the plasma fractionation market worth?

• The global plasma fractionation market size was USD 28.69 billion in 2021. The market is projected to grow from USD 30.64 billion in 2022 to USD 49.61 billion by 2029 at a CAGR of 7.1% during the period 2022-2029.

2. What are the key factors driving the market?

• Increasing demand for plasma-derived medicinal products to enhance growth

Around us:

Fortune Business Insights™ provides accurate data and innovative corporate analysis, helping organizations of all sizes make the right decisions. We tailor new solutions to our clients, helping them address the various challenges of their businesses. Our goal is to empower them with comprehensive market intelligence, providing a broad overview of the market in which they operate.

Contact us:

Fortune Business Insights™ Pvt. Ltd.

USA: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]